Streetbeat News

Earnings

CGNT

Cognyte Software Ltd has updated its FY24 outlook, expecting a revenue of $307M, which is an 8.5% growth from the previous year. The company also anticipates an EPS loss of $0.33, an improvement from the prior estimate of $0.53 loss.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 11:07 am

CGNT

Cognyte Software reported Q2 adjusted EPS of $(0.09), beating the estimate of $(0.22) by 59.09%. The company's sales of $77.05M also surpassed the estimate of $76.22M by 1.09%. However, these figures represent a decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 11:01 am

HUT

Hut 8 Mining Corp. reported that it mined 103 Bitcoin in August 2023, which translates to an average production rate of approximately 3.3 Bitcoin per day.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 10:34 am

TRNS

Transcat has entered into an amendment to a share purchase agreement dated August 31, 2021. The company expects its total earn-out obligations under the amendment to be between $3.7M and $4.5M. This is expected to result in a one-time reduction of net income of $2.7M to $3.4M for the quarter ending September 23.

Portfolio Pulse from Charles Gross

September 12, 2023 | 10:20 am

AER

CGC

LAW

ORCL

PKX

SGHT

SLRN

TNGX

Several stocks traded lower in Tuesday's pre-market session. Acelyrin's shares tumbled 58.5% as it failed to meet a primary endpoint in its analysis. Sight Sciences fell 29.3% after issuing below-estimate Q3 revenue guidance and cutting FY23 revenue guidance. Oracle dipped 9.3% despite reporting upbeat Q1 earnings, as sales fell short of expectations. Canopy Growth declined 9.5% after a 81% jump on Monday. CS Disco fell 8.2% as its co-founder stepped down as CEO. AerCap fell 4.5% after pricing its secondary offering. POSCO Holdings and Tango Therapeutics also recorded declines.

Portfolio Pulse from Lisa Levin

September 12, 2023 | 9:40 am

CGNT

CYTO

EGIO

EPM

FARM

GLBS

INNV

LSAK

MAMA

ROOT

VNCE

Several companies are scheduled to report their earnings on September 12, 2023. These include Root, Altamira Therapeutics, Vince Holding, Cognyte Software, Globus Maritime, Lesaka Technologies, Edgio, Mama's Creations, InnovAge Holding, Evolution Petroleum, and Farmer Bros. Some companies are projected to report losses, while others are expected to report earnings.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 8:39 am

Boeing Co's CEO, David Calhoun, has not returned to a traditional office setting, instead working from his two homes. This comes as other corporate leaders are urging employees to return to the office. Boeing's CFO, Brian West, also works from home. Despite Boeing's stock losing over 35% since Calhoun became CEO, the company managed to generate free cash flow last year and has targeted a free cash flow of $3-$5 billion this year.

Portfolio Pulse from Ramakrishnan M

September 12, 2023 | 7:27 am

AAPL

CGNT

EPM

INNV

QCOM

TSLA

US stocks closed higher on Monday, with the Nasdaq adding more than 1%. Tesla shares surged over 10% after Morgan Stanley upgraded the stock and raised the price target. Qualcomm shares rose around 4% after announcing a chip supply agreement with Apple. Investors are awaiting earnings results from Cognyte Software, Evolution Petroleum Corporation, and InnovAge Holding Corp.

Portfolio Pulse from Lisa Levin

September 12, 2023 | 7:04 am

EWU

The U.K. Average Earnings Index +Bonus for July was reported at 8.5%, higher than the estimated 8.2% and the revised prior of 8.4%.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 6:03 am

DKNG

NVAX

ORCL

PFE

TSLA

U.S. stocks showed positive momentum with the Nasdaq Composite, Dow Jones Industrial Average, and S&P 500 index all rising. Oracle's stock increased by 0.31% with a first-quarter revenue of $12.45 billion, marking a 9% YoY growth. Tesla's stock surged by 10.09% with Morgan Stanley analyst Adam Jonas highlighting Tesla’s custom supercomputer, Dojo, as a potential game-changer. Novavax's stock declined by 12.88% as it awaits FDA approval for its COVID-19 vaccine. DraftKings' stock dipped by 0.19% following criticism for a “Never Forget” parlay promotion. Pfizer's stock declined by 0.91% as recent data indicates a rise in Pfizer’s short percent of float.

Portfolio Pulse from Benzinga Neuro

September 12, 2023 | 2:26 am